Chlamydia is a sexually transmitted infection (STI) that often presents without symptoms. People between the ages of 15 and 24 are the most likely to contract the infection. Roughly two-thirds of ...

Chlamydia symptoms typically depend on the parts of the body where the sexually transmitted infection (STI) occurs. You might experience anal or penile discharge if these organs are involved, or you ...

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA ...

Sometimes it’s just kind of a nightmare. The scripts get written without any idea what exists or not.

Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last year. There are currently no approved vaccines to protect against ...

As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia. The FDA has granted Fast ...

simonkr/Getty Images The FDA has approved a new at-home test for two common sexually transmitted infections and a sexually transmitted disease. The test for chlamydia, gonorrhea, and ...

As rates of STIs continue to rise in the country, Australian women can now complete a rapid test themselves to test for ...

In an ideal world, teenagers would not be engaging in risky sexual activity and would not be catching sexually transmitted ...

Credit: Visby Medical. The approval was based on a clinical study that included 2203 females aged 14 years and older. The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s ...